Is the kaolin or celite activated clotting time affected by tranexamic acid? J.F.Matthias Bechtel, MD, Joachim Prosch, Hans-Hinrich Sievers, MD, Claus.

Slides:

Advertisements

Similar presentations

Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus

Advertisements

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Ten-year trends in heart valve replacement operations

Intracostal sutures decrease the pain of thoracotomy

Hans-Hinrich Sievers, MD

Short-segment colon interposition for end-stage achalasia

Immunology and failure of valved allografts in children

Amiodarone Significantly Decreases Atrial Fibrillation in Patients Undergoing Surgery for Lung Cancer Lars P. Riber, MD, PhD, Thomas D. Christensen,

Tetralogy of Fallot: surgical management individualized to the patient

Sinus node function after mitral valve surgery using the superior septal approach Hankei Shin, MD, Ryohei Yozu, MD, Shigeki Higashi, MD, Shiaki Kawada,

Platelet Transfusion in Cardiac Surgery Does Not Confer Increased Risk for Adverse Morbid Outcomes Tory McGrath, MD, Colleen Gorman Koch, MD, MS, Meng.

CTSNet: a unique educational vehicle

Assessment of heparin anticoagulation: comparison of two commercially available methods Hanne I Flom-Halvorsen, PhD, Eivind Øvrum, MD, PhD, Michel Abdelnoor,

Ten-year trends in heart valve replacement operations

What is the marginal cost for marginal risk in cardiac surgery?

Severe ischemic early liver injury after cardiac surgery

Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only Thierry P Carrel, MD, Mike Schwanda, MD,

Intravenous Diltiazem and Acute Renal Failure After Cardiac Operations

Public policy and the practicing physician

Bicuspid aortic valve aortopathy: One size fits all?

Adjuvant treatment of deep sternal wound infection with collagenous gentamycin Rainer G Leyh, MD, Claus Bartels, MD, PhD, Hans-Hinrich Sievers, MD, PhD

Who Do You Say You Are? The Annals of Thoracic Surgery

Heparin-induced thrombocytopenia and cardiac surgery

Use of Amiodarone After Major Lung Resection

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia Abdellah Aouifi, MD, Pascale Blanc, MD, Vincent.

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,

Pediatric open heart operations without diagnostic cardiac catheterization Jean-Pierre Pfammatter, MD, Pascal A Berdat, MD, Thierry P Carrel, MD, Franco.

On-pump versus off-pump coronary revascularization: evaluation of renal function Raimondo Ascione, MD, Clinton T Lloyd, Malcom J Underwood, Walter J Gomes,

Repair of aortic coarctation in patients more than 50 years of age

Hans-Hinrich Sievers, MD

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Cardiac Operations in Patients 90 Years of Age and Older

Size and distensibility of the aortic root and aortic valve function after different techniques of the Ross procedure Claudia Schmidtke, MDa, J.F.Matthias.

Michael J. Wolf, MD, Kirk R. Kanter, MD, Paul M. Kirshbom, MD, Brian E

Editorial Board, January 2010

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery Julio C Vasquez, MD, Anna Vichiendilokkul, PharmD, Syed Mahmood, MD,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

John H. Lemmer, MDa, George J. Despotis, MDb

Hans-Joachim Schäfers, MD, PhD, Diana Aicher, MD, Frank Langer, MD

Two Consecutive Open Heart Operations in a Small Child With Heparin-Induced Thrombocytopenia Type II Using Anticoagulation With Heparin and Tirofiban

Time course of proinflammatory and anti-inflammatory responses after cardiac operation: monocyte HLA-DR expression Y.John Gu, MD, PhD, Willem van Oeveren,

Isolated Aortic Coarctation in Neonates and Infants: Results of Resection and End-to- End Anastomosis Jean-Pierre Pfammatter, MD, Gerhard Ziemer, MD,

Is there a role for pneumonectomy in pulmonary metastases?1

Bradykinin preconditioning in coronary artery bypass grafting

Hans-Joachim Schäfers, MD

Anthony P.C Yim, MD, Song Wan, MD, PhD, Tak Wai Lee, Ahmed A Arifi

Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F

Intracostal sutures decrease the pain of thoracotomy

Massimo Meco, MD, Silvia Cirri, MD The Annals of Thoracic Surgery

Dual Inferior Vena Cava: Two Inferior Vena Cava Filters

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

Aprotinin is Not Associated With Postoperative Renal Impairment After Primary Coronary Surgery Gabriella Lindvall, MD, Ulrik Sartipy, MD, PhD, Torbjörn.

Neal S Goldstein, MD The Annals of Thoracic Surgery

“Transitions” for Cardiothoracic Surgeons Now Listed on the Web:

Toward a more rational approach in treating type B aortic dissection

The use of routine chest x-ray films after chest tube removal in postoperative cardiac patients James T McCormick, DO, Michael S O’Mara, MD, Pavlos K.

Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations Martin Misfeld, MD, Sven Dubbert, Sawas Eleftheriadis,

Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure Victor O. Morell, MD, Peter A.

Adnan Cobanoglu, MD, Jess M Schultz, MD The Annals of Thoracic Surgery

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

The Impact of New Technology on Cardiothoracic Surgical Practice

Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations Wulf Dietrich, Karl Schöpf, Michael Spannagl, Marianne.

Robert J Frumento, MS, MPH, Catherine M

Preoperative immunoglobulin treatment in patients with Werlhof’s disease undergoing cardiac operation Stefan Christiansen, MD, Christof Schmid, MD, Klaus.

Aortic Valve Function After Bicuspidization of the Unicuspid Aortic Valve Diana Aicher, MD, Moritz Bewarder, Michael Kindermann, MD, Hashim Abdul-Khalique,

Anti-HLA class I antibodies and pulmonary homograft function after the Ross procedure J.F.Matthias Bechtel, MD, Claus Bartels, MD, Claudia Schmidtke,

Zenker’s diverticulum in the elderly: is operation justified?

Presentation transcript:

Is the kaolin or celite activated clotting time affected by tranexamic acid? J.F.Matthias Bechtel, MD, Joachim Prosch, Hans-Hinrich Sievers, MD, Claus Bartels, MD The Annals of Thoracic Surgery Volume 74, Issue 2, Pages 390-393 (August 2002) DOI: 10.1016/S0003-4975(02)03744-X

Fig 1 Measurement of Celite activated clotting time (ACT; ▴) and kaolin activated clotting time (▾) at baseline, after the application of tranexamic acid (TA), and after the application of tranexamic acid and heparin to ex vivo blood samples of healthy volunteers. The application of tranexamic acid alone does not significantly change the baseline activated clotting time. Data are mean ± standard deviation. The Annals of Thoracic Surgery 2002 74, 390-393DOI: (10.1016/S0003-4975(02)03744-X)

Fig 2 Measurement of Celite activated clotting time (ACT; ▴) and kaolin activated clotting time (▾) in patients undergoing primary cardiac operations. No differential effect of tranexamic acid on Celite activated clotting time and kaolin activated clotting time can be observed. Data are mean ± standard deviation. The Annals of Thoracic Surgery 2002 74, 390-393DOI: (10.1016/S0003-4975(02)03744-X)